Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
CDRH 2022: Shuren Says COVID-19 Left Agency ‘Battle-Scarred’ But Also Wiser
The Agency’s Annual Report Discussed Its Top Challenges And Accomplishments For The Year That Was
Jan 30 2023
•
By
Brian Bossetta
• Source: Shutterstock
More from Regulation
More from Policy & Regulation